Todd Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-83,329
Closed -$4.24M 191
2025
Q4
$4.24M Buy
83,329
+21,957
+36% +$1.12M 0.08% 123
2025
Q3
$3.41M Buy
61,372
+3,632
+6% +$213K 0.07% 125
2025
Q2
$3.99M Buy
57,740
+16,640
+40% +$1.13M 0.09% 117
2025
Q1
$2.85M Buy
+41,100
New +$3.39M 0.07% 124
2017
Q4
Sell
-145,360
Closed -$3.5M 219
2017
Q3
$3.5M Sell
145,360
-14,800
-9% -$334K 0.1% 148
2017
Q2
$3.44M Sell
160,160
-400
-0.2% -$8.07K 0.1% 155
2017
Q1
$2.75M Buy
160,560
+18,600
+13% +$324K 0.08% 167
2016
Q4
$2.54M Sell
141,960
-215,702
-60% -$3.91M 0.08% 162
2016
Q3
$7.44M Sell
357,662
-114,522
-24% -$2.84M 0.22% 145
2016
Q2
$12.7M Buy
472,184
+99,660
+27% +$2.73M 0.41% 112
2016
Q1
$10.1M Buy
372,524
+76,008
+26% +$2.04M 0.3% 126
2015
Q4
$8.61M Sell
296,516
-106,762
-26% -$2.96M 0.26% 132
2015
Q3
$10.9M Sell
403,278
-16,674
-4% -$472K 0.34% 104
2015
Q2
$11.5M Buy
419,952
+11,010
+3% +$310K 0.31% 107
2015
Q1
$10.9M Sell
408,942
-263,272
-39% -$6.06M 0.3% 114
2014
Q4
$14.2M Buy
672,214
+106,384
+19% +$2.38M 0.4% 73
2014
Q3
$13.5M Buy
565,830
+14,868
+3% +$342K 0.39% 83
2014
Q2
$12.7M Sell
550,962
-66,504
-11% -$1.47M 0.36% 94
2014
Q1
$14.1M Sell
617,466
-834
-0.1% -$17.8K 0.41% 81
2013
Q4
$11.3M Buy
618,300
+9,740
+2% +$170K 0.33% 100
2013
Q3
$10.3M Buy
608,560
+370
+0.1% +$6.22K 0.32% 105
2013
Q2
$9.43M Buy
+608,190
New +$10.1M 0.31% 100

Other funds holding NVO

Todd Asset Management's NVO Position: Q1 2026 in Review

Todd Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 83,329 shares — an estimated $4.24M sold.

Todd Asset Management first reported a position in NVO in Q2 2013 and held it in 22 quarters. The position peaked at $14.2M in Q4 2014. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Todd Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Todd Asset Management sold 83,329 Novo Nordisk shares in Q1 2026, an estimated $4.24M.
  • Todd Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 22 quarters.
  • Todd Asset Management's Novo Nordisk position peaked at $14.2M in Q4 2014.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Todd Asset Management's 13F filing for Q1 2026, filed 12 May 2026.